Ventyx Biosciences Inc (NASDAQ: VTYX) on Monday, soared 5.96% from the previous trading day, before settling in for the closing price of $2.18. Within the past 52 weeks, VTYX’s price has moved between $1.79 and $15.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 34.66%. With a float of $54.69 million, this company’s outstanding shares have now reached $59.24 million.
The firm has a total of 80 workers. Let’s measure their productivity. In terms of profitability, gross margin is -29.37%, operating margin of -17061.06%, and the pretax margin is -15920.26%.
Ventyx Biosciences Inc (VTYX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 22.62%, while institutional ownership is 71.86%. The most recent insider transaction that took place on Apr 02 ’24, was worth 8,921. In this transaction CHIEF BUSINESS OFFICER of this company sold 1,651 shares at a rate of $5.40, taking the stock ownership to the 284,999 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 264,998 shares in total.
Ventyx Biosciences Inc (VTYX) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.92 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.9) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.66% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 14.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.79, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.22 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Analysing the last 5-days average volume posted by the [Ventyx Biosciences Inc, VTYX], we can find that recorded value of 1.09 million was lower than the volume posted last year of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 18.94%. Additionally, its Average True Range was 0.15.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 17.16%, which indicates a significant decrease from 49.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.69% in the past 14 days, which was lower than the 110.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.23, while its 200-day Moving Average is $3.56. Now, the first resistance to watch is $2.40. This is followed by the second major resistance level at $2.48. The third major resistance level sits at $2.58. If the price goes on to break the first support level at $2.22, it is likely to go to the next support level at $2.12. Now, if the price goes above the second support level, the third support stands at $2.04.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 163.25 million based on 70,499K outstanding shares. Right now, sales total 0 K and income totals -192,960 K. The company made 0 K in profit during its latest quarter, and -31,950 K in sales during its previous quarter.
